Home / Recalls / Glaxosmithkline Consumer Healthcare Holdings DBA Haleon / D-0183-2023

D-0183-2023 Class I Terminated

Recalled by Glaxosmithkline Consumer Healthcare Holdings DBA Haleon — Warren, NJ

Recall Details

Product Type: Drugs
Report Date: February 1, 2023
Initiation Date: December 6, 2022
Termination Date: February 26, 2024
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 209,292 capsules

Product Description

Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5

Reason for Recall

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Distribution Pattern

Nationwide in the USA.

Code Information

Lot: R93517, R94072, R94073, Exp 02/29/2024; T00655, Exp 03/31/2025